Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
825.83
725.98
736.59
778.72
855.07
516.94
488.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
825.83
725.98
736.59
778.72
855.07
516.94
488.90
Raw Material Cost
666.19
629.33
623.45
586.78
415.58
344.75
342.61
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
91.00
81.08
81.46
0.00
0.00
67.56
59.02
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.29
1.83
4.86
6.53
4.97
11.32
6.46
Selling and Distribution Expenses
72.38
64.30
62.20
87.86
131.49
80.62
71.54
Other Expenses
-5.27
-4.33
-5.05
3.05
2.81
-5.22
-4.51
Total Expenditure (Excl Depreciation)
779.17
733.20
721.50
711.68
580.18
452.10
434.55
Operating Profit (PBDIT) excl Other Income
46.7
-7.199999999999999
15.1
67
274.9
64.80000000000001
54.400000000000006
Other Income
28.79
21.16
52.40
27.56
-32.00
14.84
12.72
Operating Profit (PBDIT)
139.27
44.34
115.39
165.27
303.84
113.53
91.10
Interest
2.29
1.83
4.86
6.53
4.97
11.32
6.46
Exceptional Items
-8.10
-9.89
-0.98
-1.47
-0.98
0.52
1.00
Gross Profit (PBDT)
159.65
96.65
113.13
191.94
439.49
172.19
146.29
Depreciation
79.79
77.92
73.03
77.23
74.21
53.56
33.24
Profit Before Tax
49.09
-45.31
36.52
80.04
223.67
49.18
52.40
Tax
11.83
8.89
6.09
8.22
33.70
11.42
9.81
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
29.42
-54.06
31.48
75.76
197.44
47.03
44.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
29.42
-54.06
31.48
75.76
197.44
47.03
44.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
7.83
-0.14
-1.05
-3.93
-7.47
-9.27
-1.96
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
37.26
-54.20
30.44
71.82
189.97
37.76
42.58
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,260.83
1,254.68
1,327.98
1,320.48
1,304.64
883.81
791.25
Earnings per share (EPS)
0.17
-0.32
0.18
0.44
1.17
0.3
0.29
Diluted Earnings per share
0.17
-0.32
0.18
0.44
1.17
0.3
0.29
Operating Profit Margin (Excl OI)
3.72%
-7.54%
-1.36%
7.77%
30.6%
8.73%
9.23%
Gross Profit Margin
15.61%
4.49%
14.87%
20.2%
34.84%
19.87%
17.52%
PAT Margin
3.56%
-7.45%
4.27%
9.73%
23.09%
9.1%
9.11%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 13.75% vs -1.44% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 168.82% vs -278.29% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 376.29% vs -63.17% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 27.78% vs -63.27% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Zhejiang Shengda Bio-Pharm Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
825.83
0
825.83
Other Operating Income
0.00
0.00
0.00
Total Operating income
825.83
0
825.83
Raw Material Cost
666.19
0
666.19
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
91.00
0
91.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.29
0
2.29
Selling and Distribution Expenses
72.38
0
72.38
Other Expenses
-5.27
0.00
-5.27
Total Expenditure (Excl Depreciation)
779.17
0
779.17
Operating Profit (PBDIT) excl Other Income
46.67
0.00
46.67
Other Income
28.79
0
28.79
Operating Profit (PBDIT)
139.27
0
139.27
Interest
2.29
0
2.29
Exceptional Items
-8.10
0
-8.10
Gross Profit (PBDT)
159.65
0
159.65
Depreciation
79.79
0
79.79
Profit Before Tax
49.09
0
49.09
Tax
11.83
0
11.83
Provisions and contingencies
0
0
0.00
Profit After Tax
29.42
0
29.42
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
29.42
0
29.42
Share in Profit of Associates
0
0
0.00
Minority Interest
7.83
0
7.83
Other related items
0.00
0.00
0.00
Consolidated Net Profit
37.26
0
37.26
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,260.83
0
1,260.83
Earnings per share (EPS)
0.17
0
0.17
Diluted Earnings per share
0.17
0
0.17
Operating Profit Margin (Excl OI)
3.72%
0%
0.00
3.72%
Gross Profit Margin
15.61%
0%
0.00
15.61%
PAT Margin
3.56%
0%
0.00
3.56%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 82.58 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 13.75% vs -1.44% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 3.73 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 168.82% vs -278.29% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.05 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 376.29% vs -63.17% in Dec 2023
Annual - Interest
Interest 0.23 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 27.78% vs -63.27% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.72%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






